Poseida Therapeutics Inc (PSTX)
9.49
+0.01
(+0.11%)
USD |
NASDAQ |
Dec 24, 16:00
Poseida Therapeutics Total Liabilities (Quarterly): 206.37M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Galectin Therapeutics Inc | 121.45M |
| Revance Therapeutics Inc | 624.59M |
| Sage Therapeutics Inc | 70.60M |
| Alector Inc | 397.09M |
| Phathom Pharmaceuticals Inc | 574.16M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 293.58M |
| Shareholders Equity (Quarterly) | 87.21M |
| Debt to Equity Ratio | 0.6755 |
| Current Ratio | 3.203 |
| Net Debt Paydown Yield | -0.04% |